RETROTHERAPY, LLC

Basic Information

4519 GRETNA ST
BETHESDA, MD, 20814-3956

Company Profile

n/a

Additional Details

Field Value
DUNS: 145949066
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 1


  1. Optimizing correction of the Huntington's disease mutation by trans-splicing

    Amount: $226,921.00

    DESCRIPTION provided by applicant Recent studies by my laboratory and collaborators and by others have demonstrated that RNA trans splicing can correct mutations in many different genes in a wide r ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Correcting Aberrant Splicing of the Human CD22 Gene

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): B-precursor acute lymphoblastic leukemia (BPL) is the most common form of cancer in children and adolescents. This project addresses an urgent and unmet need for t ...

    SBIR Phase I 2014 Department of Health and Human Services
  3. Development of tools to modify globin gene expression in stem cells

    Amount: $521,305.00

    DESCRIPTION (provided by applicant): Development of tools to modify globin gene expression in stem cells The objective of this proposal is to develop a treatment for patients with sickle cell disease. ...

    SBIR Phase I 2011 Department of Health and Human Services
  4. Optimization of a method to reduce expression of progerin, the cause of HGPS (Pro

    Amount: $372,089.00

    DESCRIPTION (provided by applicant): This proposal seeks to develop a specific and efficient means to reduce or eliminate the production of the progerin protein, the cause of the premature aging dise ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government